<DOC>
	<DOCNO>NCT00174200</DOCNO>
	<brief_summary>To assess effect risperidone 2 mg daily ( QD ) differential sensitivity 2 spatial work memory test ( GMLT MDR ) non-agitated , drug-naive patient suffer first-episode schizophrenia/schizophreniform disorder .</brief_summary>
	<brief_title>Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Male female , 18 50 year old , antipsychoticnaive , nonagitated patient diagnose firstepisode schizophrenia schizophreniform disorder . Evidence history clinically significant medical nonmedical impairment , opinion investigator , would affect safety patient interfere evaluation trial result ; Patients history substance ( included alcohol ) dependence within 12 month abuse within 3 month enrollment , test positive illicit drug Screening urine toxicology test Pregnant nursing female ; female childbearing potential unwilling unable use acceptable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>